{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:38:20Z","timestamp":1763037500496,"version":"3.41.2"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.01862","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T04:48:10Z","timestamp":1597207690000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["DNA Encapsidation and Capsid Assembly Are Underexploited Antiviral Targets for the Treatment of Herpesviruses"],"prefix":"10.3389","volume":"11","author":[{"given":"Tara","family":"Keil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda","family":"Coombs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Moffat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Visalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3233\/JAD-170966","article-title":"HSV-1-Specific IgG subclasses distribution and serum neutralizing activity in Alzheimer\u2019s disease and in mild cognitive impairment.","volume":"63","author":"Agostini","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3109\/01443615.2015.1127905","article-title":"Congenital varicella syndrome: a systematic review.","volume":"36","author":"Ahn","year":"2016","journal-title":"J. Obstetr. Gynaecol."},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511545313","author":"Arvin","year":"2007","journal-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1007\/s12035-018-1388-y","article-title":"The possibility of an infectious etiology of Alzheimer disease.","volume":"56","author":"Ashraf","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients.","volume":"70","author":"Azevedo","year":"2015","journal-title":"Clinics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9077","DOI":"10.1128\/JVI.75.19.9077-9086.2001","article-title":"A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products.","volume":"75","author":"Buerger","year":"2001","journal-title":"J. Virol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3201\/eid0503.990306","article-title":"Human herpesvirus 6: an emerging pathogen.","volume":"5","author":"Campadelli-Fiume","year":"1999","journal-title":"Emerg. Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev-pathol-012513-104656","article-title":"Gammaherpesviruses and lymphoproliferative disorders.","volume":"9","author":"Cesarman","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","article-title":"Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation.","volume":"370","author":"Chemaly","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/bloodadvances.2018016493","article-title":"Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation.","volume":"2","author":"Chen","year":"2018","journal-title":"Blood Adv."},{"key":"B11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1358\/dot.2018.54.6.2833982","article-title":"Letermovir for prophylaxis of cytomegalovirus in allogeneic hematopoietic stem cell recipients.","volume":"54","author":"Cho","year":"2018","journal-title":"Drugs Today"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1128\/AAC.01623-15","article-title":"Rapid in vitro evolution of human cytomegalovirus UL56 mutations that confer letermovir resistance.","volume":"59","author":"Chou","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2017.10.019","article-title":"A third component of the human cytomegalovirus terminase complex is involved in letermovir resistance.","volume":"148","author":"Chou","year":"2017","journal-title":"Antiviral Res."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00922-18","article-title":"New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by In Vitro Exposure to Letermovir and Ganciclovir.","volume":"62","author":"Chou","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.antiviral.2014.07.007","article-title":"beta-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.","volume":"110","author":"De","year":"2014","journal-title":"Antiviral Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1016\/j.bmcl.2004.06.025","article-title":"Thiourea inhibitors of herpesviruses. Part 3: inhibitors of varicella zoster virus.","volume":"14","author":"Di Grandi","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/infdis\/jiz577","article-title":"Letermovir resistance analysis in a clinical trial of cytomegalovirus prophylaxis for hematopoietic stem cell transplant recipients.","volume":"221","author":"Douglas","year":"2019","journal-title":"J. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2147\/IDR.S180908","article-title":"Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review.","volume":"12","author":"El Helou","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"B19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/17512433.2018.1500897","article-title":"Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients.","volume":"11","author":"Foolad","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2019.001","article-title":"In vivo emergence of UL56 C325Y cytomegalovirus resistance to letermovir in a patient with acute myeloid leukemia after hematopoietic cell transplantation.","volume":"11","author":"Frietsch","year":"2019","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/QCO.0000000000000375","article-title":"Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic options.","volume":"30","author":"Fuji","year":"2017","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00362","article-title":"Role of microbes in the development of Alzheimer\u2019s disease: state of the art - an international symposium presented at the 2017 IAGG Congress in San Francisco.","volume":"9","author":"Fulop","year":"2018","journal-title":"Front. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.antiviral.2018.11.005","article-title":"Targeting the terminase: an important step forward in the treatment and prophylaxis of human cytomegalovirus infections.","volume":"161","author":"Gentry","year":"2019","journal-title":"Antiviral Res."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection.","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1212\/CON.0000000000000246","article-title":"Varicella-zoster virus infections.","volume":"21","author":"Gilden","year":"2015","journal-title":"Continuum"},{"key":"B26","doi-asserted-by":"publisher","first-page":"10884","DOI":"10.1128\/JVI.05265-11","article-title":"The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.","volume":"85","author":"Goldner","year":"2011","journal-title":"J. Virol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.antiviral.2015.01.006","article-title":"Phenotypic characterization of two naturally occurring human Cytomegalovirus sequence polymorphisms located in a distinct region of ORF UL56 known to be involved in in vitro resistance to letermovir.","volume":"116","author":"Goldner","year":"2015","journal-title":"Antiviral Res."},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.1201\/b13787","author":"Grayson","year":"2010","journal-title":"Kucers\u2019 the Use of Antibiotics : A Clinical Review of Antibacterial, Antifungal, Antiparasitic and Antiviral Drugs"},{"key":"B29","first-page":"928","article-title":"Genital herpes: a review.","volume":"93","author":"Groves","year":"2016","journal-title":"Am. Fam. Physician"},{"journal-title":"Cytomegalovirus.","year":"2019","author":"Gupta","key":"B30"},{"key":"B31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/1673-5374.226380","article-title":"Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology.","volume":"13","author":"Hogestyn","year":"2018","journal-title":"Neural Regen. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/rmv.1816","article-title":"Host genetics of Epstein-Barr virus infection, latency and disease.","volume":"25","author":"Houldcroft","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"11604","DOI":"10.1128\/JVI.01130-07","article-title":"Identification of acetylated, tetrahalogenated benzimidazole D-ribonucleosides with enhanced activity against human cytomegalovirus.","volume":"81","author":"Hwang","year":"2007","journal-title":"J. Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"12198","DOI":"10.1128\/JVI.01280-12","article-title":"Identification of a varicella-zoster virus replication inhibitor that blocks capsid assembly by interacting with the floor domain of the major capsid protein.","volume":"86","author":"Inoue","year":"2012","journal-title":"J. Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/infdis\/jiz642","article-title":"De novo genotypic heterogeneity in the UL56 region in cytomegalovirus-infected tissues: implications for primary Letermovir Resistance.","volume":"221","author":"Jo","year":"2019","journal-title":"J. Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/cmdc.201800283","article-title":"Hydroxypyridonecarboxylic acids as inhibitors of human cytomegalovirus pUL89 Endonuclease.","volume":"13","author":"Kankanala","year":"2018","journal-title":"ChemMedChem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"635","DOI":"10.11406\/rinketsu.60.635","article-title":"[Cytomegalovirus infections following allogeneic hematopoietic stem cell transplantation: prophylaxis and treatment].","volume":"60","author":"Katayama","year":"2019","journal-title":"Rinsho Ketsueki"},{"key":"B38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/WNO.0000000000000721","article-title":"Neurological and ophthalmological manifestations of Varicella Zoster Virus.","volume":"39","author":"Kedar","year":"2019","journal-title":"J. Neuroophthalmol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection.","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104549","article-title":"In-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products.","volume":"169","author":"Komatsu","year":"2019","journal-title":"Antiviral Res."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032207","article-title":"Direct binding of a hepatitis C virus inhibitor to the viral capsid protein.","volume":"7","author":"Kota","year":"2012","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2018.03.025","article-title":"The lysosome system is severely impaired in a cellular model of neurodegeneration induced by HSV-1 and oxidative stress.","volume":"68","author":"Kristen","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1111\/bcp.13376","article-title":"Pharmacokinetics and safety of the anti-human cytomegalovirus drug letermovir in subjects with hepatic impairment.","volume":"83","author":"Kropeit","year":"","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1111\/bcp.13292","article-title":"Pharmacokinetics and safety of letermovir, a novel anti-human cytomegalovirus drug, in patients with renal impairment.","volume":"83","author":"Kropeit","year":"","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/cpdd.388","article-title":"Pharmacokinetics and safety of letermovir coadministered with cyclosporine A or tacrolimus in healthy subjects.","volume":"7","author":"Kropeit","year":"2018","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"462.e1","DOI":"10.1016\/j.ajog.2016.04.003","article-title":"In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.","volume":"215","author":"Leruez-Ville","year":"2016","journal-title":"Am. J. Obstetr. Gynecol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1097\/PHH.0000000000000819","article-title":"Varicella vaccination among US adolescents: coverage and missed opportunities, 2007-2014.","volume":"25","author":"Leung","year":"2019","journal-title":"J. Public Health Manage. Pract."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1128\/AAC.01596-09","article-title":"In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246.","volume":"54","author":"Lischka","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1016\/S1473-3099(19)30107-0","article-title":"Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7).","volume":"19","author":"Ljungman","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140765","article-title":"Global and regional estimates of prevalent and incident herpes simplex virus Type 1 infections in 2012.","volume":"10","author":"Looker","year":"","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1016\/S2214-109X(16)30362-X","article-title":"First estimates of the global and regional incidence of neonatal herpes infection.","volume":"5","author":"Looker","year":"2017","journal-title":"Lancet Global Health"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114989","article-title":"Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012.","volume":"10","author":"Looker","year":"","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/17474086.2016.1174571","article-title":"Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation.","volume":"9","author":"Maffini","year":"2016","journal-title":"Expert Rev. Hematol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation.","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-019-0199-9","article-title":"Congenital myopathy with hanging big toe due to homozygous myopalladin (MYPN) mutation.","volume":"9","author":"Merlini","year":"2019","journal-title":"Skelet. Muscle"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.11406\/rinketsu.60.1337","article-title":"[Management of cytomegalovirus infection after hematopoietic stem cell transplantation].","volume":"60","author":"Mori","year":"2019","journal-title":"Rinsho Ketsueki"},{"key":"B57","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1093\/infdis\/jiy425","article-title":"Varicella Zoster Virus Vasculopathy.","volume":"218","author":"Nagel","year":"2018","journal-title":"J. Infect. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jneuroim.2017.03.014","article-title":"Varicella zoster virus vasculopathy: the expanding clinical spectrum and pathogenesis.","volume":"308","author":"Nagel","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1030","article-title":"High-dose CMV hyperimmune globulin (HIG) and maternal CMV DNAemia independently predict infant outcome in pregnant women with a primary cytomegalovirus (CMV) infection.","author":"Nigro","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-62703-788-4_2","article-title":"Overview of human cytomegalovirus pathogenesis.","volume":"1119","author":"Nogalski","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1242\/dmm.026674","article-title":"HSV presence in brains of individuals without dementia: the TASTY brain series.","volume":"9","author":"Olsson","year":"2016","journal-title":"Dis. Models Mech."},{"key":"B62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.antiviral.2014.08.014","article-title":"Human cytomegalovirus (CMV) susceptibility to currently approved antiviral drugs does not impact on CMV terminase complex polymorphism.","volume":"111","author":"Pilorge","year":"2014","journal-title":"Antiviral Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.antiviral.2019.01.011","article-title":"Clinical development of letermovir and maribavir: overview of human cytomegalovirus drug resistance.","volume":"163","author":"Piret","year":"2019","journal-title":"Antiviral Res."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1514921","article-title":"The role of CMV in glioblastoma and implications for immunotherapeutic strategies.","volume":"8","author":"Rahman","year":"2019","journal-title":"Oncoimmunology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-virology-100114-055212","article-title":"Mechanisms of DNA packaging by large double-stranded DNA viruses.","volume":"2","author":"Rao","year":"2015","journal-title":"Annu. Rev. Virol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/MOT.0000000000000541","article-title":"Drug-resistant cytomegalovirus: clinical implications of specific mutations.","volume":"23","author":"Razonable","year":"2018","journal-title":"Curr. Opin. Organ Transplant."},{"key":"B67","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.antiviral.2010.03.007","article-title":"Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice.","volume":"86","author":"Rowe","year":"2010","journal-title":"Antiviral Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"11540","DOI":"10.1128\/JVI.01745-14","article-title":"Characterization of the mode of action of a potent dengue virus capsid inhibitor.","volume":"88","author":"Scaturro","year":"2014","journal-title":"J. Virol."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1036","article-title":"The value of hyperimmune globulin (HIG) in pregnancies complicated by cytomegalovirus infection: a continuing saga.","author":"Schleiss","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3233\/JAD-140822","article-title":"Herpes viruses increase the risk of Alzheimer\u2019s disease: a meta-analysis.","volume":"47","author":"Steel","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/tri.12225","article-title":"Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study.","volume":"27","author":"Stoelben","year":"2014","journal-title":"Transplant Int."},{"key":"B72","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/JVI.72.1.717-725.1998","article-title":"Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product.","volume":"72","author":"Underwood","year":"1998","journal-title":"J. Virol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"9054","DOI":"10.1128\/jvi.74.19.9054-9061.2000","article-title":"Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: resistance maps to the UL6 gene.","volume":"74","author":"van Zeijl","year":"2000","journal-title":"J. Virol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"7973","DOI":"10.1128\/JVI.00376-14","article-title":"The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.","volume":"88","author":"Visalli","year":"2014","journal-title":"J. Virol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1128\/jvi.77.4.2349-2358.2003","article-title":"Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication.","volume":"77","author":"Visalli","year":"2003","journal-title":"J. Virol."},{"key":"B76","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-3542(03)00108-6","article-title":"DNA encapsidation as a target for anti-herpesvirus drug therapy.","volume":"59","author":"Visalli","year":"2003","journal-title":"Antiviral Res."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02152-16","article-title":"Inhibition of human cytomegalovirus pUL89 terminase subunit blocks virus replication and genome cleavage.","volume":"91","author":"Wang","year":"2017","journal-title":"J. Virol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1056\/NEJM199209103271108","article-title":"Acyclovir: a decade later.","volume":"327","author":"Whitley","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/1348-0421.12507","article-title":"Characterization of an anti-varicella-zoster virus compound that targets the portal protein encoded by ORF54.","volume":"61","author":"Yasui","year":"2017","journal-title":"Microbiol. Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/jmv.23954","article-title":"Maternal, fetal, and neonatal parameters for prognosis and counseling of HCMV congenital infection.","volume":"86","author":"Zavattoni","year":"2014","journal-title":"J. Med. Virol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.01862\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T06:31:28Z","timestamp":1616913088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.01862\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":80,"alternative-id":["10.3389\/fmicb.2020.01862"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.01862","relation":{},"ISSN":["1664-302X"],"issn-type":[{"type":"electronic","value":"1664-302X"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"article-number":"1862"}}